Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Steroid Biochemistry and Molecular Biology|October 26, 2018
Negative correlation between testosterone and TNF-α in umbilical cord serum favors a weakened immune milieu in the human male fetoplacental unitAndrea Olmos-Ortiz, Janice García-Quiroz, Ali Halhali, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 27, 2021
Placentas associated with female neonates from pregnancies complicated by urinary tract infections have higher cAMP content and cytokines expression than malesAndrea Olmos-Ortiz, Alberto Olivares-Huerta, Janice García-Quiroz, et al.
Journal of Reproductive Immunology|December 23, 2023
Effects of calcitriol upon TGF-βs and their receptors in trophoblast cellsNancy Noyola-Martínez, Mayel Chirinos, Ixchel Ramírez-Camacho, et al.
Anticancer Research|August 5, 2010
Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cellsEuclides Avila, Rocío García-Becerra, Jesús Adrián Rodríguez-Rasgado, et al.
Experimental Cell Research|November 26, 2009
Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cellsRocío García-Becerra, Lorenza Díaz, Javier Camacho, et al.
Molecular and Cellular Endocrinology|October 13, 2023
Transcriptional landscape of human trophoblast cells treated with calcitriol and TGF-β1Sandra Romero-Córdoba, Mayel Chirinos, Nancy Noyola-Martínez, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 24, 2016
Evidence of sexual dimorphism in placental vitamin D metabolism: Testosterone inhibits calcitriol-dependent cathelicidin expressionAndrea Olmos-Ortiz, Janice García-Quiroz, Rebeca López-Marure, et al.
BMC Cancer|April 1, 2014
Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approachNancy Santos-Martínez, Lorenza Díaz, David Ordaz-Rosado, et al.
Plos One|September 18, 2012
Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapyJanice García-Quiroz, Rocío García-Becerra, David Barrera, et al.
BMC Cancer|October 5, 2014
In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumorsJanice García-Quiroz, Rocío García-Becerra, Nancy Santos-Martínez, et al.
Pageof 5